

Thymosin Alpha-1 is a 28-residue N-acetylated peptide originally isolated from thymosin fraction 5, a thymic tissue extract, and later fully characterised and synthesised.
Thymosin Alpha-1 is a 28-residue N-acetylated peptide originally isolated from thymosin fraction 5, a thymic tissue extract, and later fully characterised and synthesised.
The sequence is unusually acidic - it carries a high proportion of aspartate and glutamate residues, giving it a low isoelectric point and excellent aqueous solubility relative to peptides of similar length.
The N-terminal acetylation is present in the native molecule and is confirmed as part of the identity assay; deacetylated material is a recognised synthesis impurity and is resolved by the HPLC method used at release.
| Compound name | Thymosin Alpha-1 |
| Classification | Cellular research compound |
| CAS number | 62304-98-7 |
| Molecular formula | C129H215N33O55 |
| Molecular weight | 3108.3 g/mol |
| Sequence | Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH |
| Purity (this lot) | 99.4% by RP-HPLC |
| Endotoxin | <0.5 EU/mg by LAL |
| Appearance | White lyophilized powder |
| Vial size | 10 mg |
| Solubility | Freely soluble in water |
| Storage | Lyophilized: -20 C, desiccated. Reconstituted: 2-8 C, use within 30 days. |
| Released lot | PS-1947064 |
Vials arrive lyophilized and sealed under nitrogen. Bring the vial fully to room temperature before breaking the seal — opening a cold vial condenses atmospheric moisture onto the cake.
Direct diluent gently against the inside wall of the vial rather than onto the cake, and allow the material to dissolve without agitation. Vortexing shears longer sequences and introduces air.
Lyophilized: -20 C, desiccated. Reconstituted: 2-8 C, use within 30 days.
A full walkthrough is in the reconstitution guide, and the calculator will work out concentration and draw volume for this vial size.
Standard laboratory practice applies: appropriate personal protective equipment, no consumption, no administration to humans or animals, and disposal in accordance with institutional protocol and local regulation.
Both certificates below were generated against this specific lot and published before it was released to stock. Enter the lot number in the certificate lookup to retrieve them at any time. New to reading these? See how to read a certificate of analysis.
A high proportion of acidic residues gives it a low pI and strong aqueous solubility.
Yes, and it is confirmed on every lot. Deacetylated material is a known impurity that the release HPLC method resolves.
The thymic tissue extract from which this peptide was originally isolated before it was sequenced and synthesised.
Thymosin Alpha-1 is supplied for in-vitro laboratory research only. It is not a drug, dietary supplement, food or cosmetic, is not approved by the FDA for any use in humans or animals, and no dosing guidance is published for it. Nothing on this page is a therapeutic, structure–function or health claim. Purchasers must be 21 or over and are responsible for compliance with all applicable law. Full terms of supply.